Worth Magazine
Worth is a U.S.-based magazine dedicated to finance, wealth management, and lifestyle, established in 1986 and revitalized by Sandow in 2009. It caters to affluent readers by tackling financial, legal, and lifestyle topics relevant to high-net-worth individuals. Each edition is divided into four main parts: "Make," which emphasizes entrepreneurship and earning money; "Grow," focusing on investment strategies and wealth management; "Live," showcasing philanthropy, lifestyle choices, and passion-driven investments; and "Creator," which explores luxury goods, services, and experiences.
Outlet metrics
Global
#1140243
United States
#451210
Finance/Finance
#4578
Articles
-
5 days ago |
worth.com | Dan Costa
It was a conversation that moved from cleft palate surgeries in India to AI-powered eyewear in the U.S.—and managed to touch on everything from mental health deserts to drug discovery. Hosted by Worth Media Group and the VSP Global Innovation Center at Civic Hall, the event “AI for Access” brought together leaders from across healthcare, technology, and social innovation to explore how artificial intelligence is redefining who receives care, when, and how.
-
1 week ago |
worth.com | Dan Costa
We’re not yet at the point where robots are performing surgery independently, and according to the experts driving this transformation, that’s not the goal. “The robots are not doing the operations,” said Dr. Ed Chekan, Director of Medical Affairs at Asensus Surgical, “but they are helping us see what we couldn’t see before.”It’s a critical distinction in a field crowded with hype.
-
1 week ago |
worth.com | Dan Costa
We’re aging differently than we used to—but not necessarily better. That’s the central message from Diane Ty, Managing Director of the Center for the Future of Aging at the Milken Institute, who sat down with me during the Milken Global Conference to unpack the changing dynamics of longevity, healthcare, and caregiving in America. “We’re all about advancing healthy longevity and financial security for all,” Ty told me.
-
1 week ago |
worth.com | Dan Costa
In a world saturated with daily antidepressants and marginal gains, Doug Drysdale is betting on a radical reset. As CEO of Cybin, a clinical-stage psychedelic therapeutics company, Drysdale is leading one of the boldest pharmaceutical experiments in mental health: using modified psychedelic compounds to not just ease symptoms—but potentially cure depression. “What we’re working on is a real paradigm shift in treating mental health,” Drysdale told me at the Milken Global Conference in Los Angeles.
-
1 week ago |
worth.com | Dan Costa
When ChatGPT went public, it didn’t just launch a product—it detonated a mindset shift. Suddenly, everyone from junior analysts to C-suite execs could tinker with large language models and grasp what was coming: a generational change in how businesses operate. It was a moment of revelation, followed almost immediately by a scramble. Strategies were rewritten. Boards demanded action. Budgets exploded.
Worth Magazine journalists
Contact details
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →